StreetInsider.com News Articles

Form 6-K MindWalk Holdings Corp. For: Jun 02

Tue, 02 Jun 2026 10:32:00 -0400

si-local-file:///var/storage/secattach/20260602/26589416.html

Form 6-K MindWalk Holdings Corp. For: Jun 02

Tue, 02 Jun 2026 10:32:00 -0400

si-local-file:///var/storage/secattach/20260602/26589416.html

MindWalk reports dengue antibodies cross-react with all four serotypes

Tue, 02 Jun 2026 07:20:37 -0400

MindWalk Holdings Corp. (NASDAQ: HYFT) announced preclinical data showing that animals immunized with immunogens designed using its HYFT platform generated antibodies that cross-reacted with antigens from all four dengue serotypes.

The company's HYFT technology computationally identified a pan-serotype dengue target before immunization began. The subsequent animal studies showed that immunogens designed around this predicted target elicited antibodies recognizing all four dengue serotypes, while scrambled-sequence controls did not demonstrate the same cross-serotype recognition.

The results were reproduced across two independent campaigns using different immunogen formats and adjuvants. MindWalk stated this represents the first public evidence that its platform can connect computational predictions to

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp

Tue, 02 Jun 2026 07:20:00 -0400

HYFT® technology computationally identified and prioritized a pan-serotype dengue target before immunization. Preclinical data support the prediction at the binding level: immunization with immunogens designed on the predicted target elicited antibodies that cross-react with antigens of all four dengue serotypes, and scrambled-sequence controls support that the response is specific to the designed immunogen rather than background reactivity.

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (Nasdaq: HYFT) today reported preclinical dengue data that support a computational prediction its HYFT® platform generated before any animal was immunized. HYFT® computationally identified a candidate pan-serotype structural target on the dengue virus. The subsequent

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp

Tue, 02 Jun 2026 07:20:00 -0400

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp

Tue, 02 Jun 2026 07:20:00 -0400

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp

Tue, 02 Jun 2026 07:20:00 -0400

Form 6-K MindWalk Holdings Corp. For: May 27

Wed, 27 May 2026 09:42:00 -0400

si-local-file:///var/storage/secattach/20260527/26554931.html

Form 6-K MindWalk Holdings Corp. For: May 27

Wed, 27 May 2026 09:42:00 -0400

si-local-file:///var/storage/secattach/20260527/26554931.html

MindWalk launches pandemic response platform for RNA virus outbreaks

Wed, 27 May 2026 08:03:14 -0400

MindWalk Holdings Corp. (NASDAQ: HYFT) announced the launch of its Pandemic Response Platform, designed for outbreak preparedness and countermeasure development against RNA viruses. The platform utilizes the company's HYFT biological pattern system and LensAI platform.

The announcement comes as two World Health Organization-declared emergencies highlight gaps in current vaccine coverage. The Bundibugyo Ebola outbreak illustrates this challenge, as the only approved Ebola vaccine was developed for the Zaire strain, leaving no approved vaccine for the structurally distinct Bundibugyo species.

The platform targets structural constraints that RNA viruses must preserve across variants, rather than focusing on surface proteins that mutate rapidly. According to

MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage